insight
✂️ 성형 🏥 중증 🌐 전체
← 뒤로

Tarlatamab: Precision Delta-Like Ligand 3 Bispecific T-Cell Engager for Malignancies Beyond De Novo Small Cell Lung Cancer?

JCO precision oncology 2026 Vol.10(4) p. e2600008

Sehgal K

원문 ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Sehgal K (2026). Tarlatamab: Precision Delta-Like Ligand 3 Bispecific T-Cell Engager for Malignancies Beyond De Novo Small Cell Lung Cancer?. JCO precision oncology, 10(4), e2600008. https://doi.org/10.1200/PO-26-00008
MLA Sehgal K. "Tarlatamab: Precision Delta-Like Ligand 3 Bispecific T-Cell Engager for Malignancies Beyond De Novo Small Cell Lung Cancer?." JCO precision oncology, vol. 10, no. 4, 2026, pp. e2600008.
PMID 41990297
DOI 10.1200/PO-26-00008

같은 제1저자의 인용 많은 논문 (2)